Estados Unidos · Bolsas y cotizaciones · Nasdaq
Zymeworks Authorized To Buy Back Up To $200 Mln Of Shares
Resumen detallado
(RTTNews) - Zymeworks Inc. (ZYME), a biotechnology company, said Monday that its Board has authorized a second share repurchase program of up to $200 million, which is expected to…
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.nasdaq.com)


